a public good project by the
Synthesis
Company
of California

© 2026

Abdul Rouf Banday | doi.page

0 works0 citations0 h-index

Abdul Rouf Banday

National Institutes of Health(US)National Cancer Institute(US)Center for Cancer Research(US)

Publications by Year

Research Areas

RNA Research and Splicing, RNA modifications and cancer, Epigenetics and DNA Methylation, Single-cell and spatial transcriptomics, RNA and protein synthesis mechanisms

Most-Cited Works

→ Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor(2020)266 cited
→ Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors(2016)190 cited
→ Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries(2022)135 cited
→ APOBEC Mutagenesis and Copy-Number Alterations Are Drivers of Proteogenomic Tumor Evolution and Heterogeneity in Metastatic Thoracic Tumors(2019)107 cited
→ APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential(2023)62 cited
→ APOBEC-mediated Mutagenesis as a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer(2019)53 cited

→ Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms(2015)

48 cited

→ Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry(2016)45 cited

→ Determination of the cationic amphiphilic drug–DNA binding mode and DNA-assisted fluorescence resonance energy transfer amplification(2013)41 cited

→ Interferons and viruses induce a novel primate-specific isoform dACE2 and not the SARS-CoV-2 receptor ACE2(2020)25 cited